Company Introduction

Company introduction

Products
Product Details
Botulax There are three product types, 50, 100, and 200 units, per vial. The ap-
Hugel Injection proved indications are blepharospasm and glabellar line improvement,
(Botulinum and will be expanded to post stroke upper limb spasticity and pediatric
Toxin Type A) cerebral palsy. Currently, expansion of the range of treatment such as
hyperhidrosis, painless liquid product, non-animal origin products, and
etc. are under development.
Hugel Inc. was established in 2001 aiming to The Chaeum It is a low-pain hyaluronic acid product containing lidocaine and
improve the quality of humans’ blissful lives by (‌Crosslinked consisted of four types, No.1, No. 2, No. 3 and No. 4, according to its
providing “healthy and long-lasting beauty to hyaluronic viscoelasticity. The Chaeum is provided with a dedicated injection
acid) cartridge which considers the convenient injection and patients’ safety.
human kind” It functions as temporary facial wrinkle improvement and tissue resto-
ration.
Hugel Inc. developed biological product “Botulax” using botulinum tox-
Wellage It is a skin cosmetic line enhancing moisturizing and antioxidant
in and gained 40% of market share in Korea. Since 2009, we have been
(Cosmetics) functions, being consisted of ‘Vital Neo Water-Lock-Toner’, ‘Enrich
exporting “Botulax” to 19 countries including Asia, such as Japan, Thai-
Emulsion’, and ‘Nutritious Rich Cream’. This bio-cosmetic, Wellage,
land, Philippine and etc., and South America, such as Peru, Paraguay,
provides proper cares per each skin type as cosmeceuticals with use of
Bolivia, Chile, Columbia, Ecuador, and etc.
key ingredients such as nero-peptide, melatoine and plant-based stem
In more than 30 countries, the registration including clinical trials is in
cell extractions.
progress, expecting to get approval for Russia in 2016, China and Eu-
rope in 2018, the United States in 2019. In order to ensure the increas- Bluerose It is a facial fixing thread having Polydioxanone as main ingredient. It
ing market demand, the second plant with cGMP standards has been (Facial tissue is absorbable in human body as medical thread for facial tissue fixing,
completed and will be operated from 2016. fixing thread) which has skin lifting effect by barbs around the thread when inserted
In 2014, we launched ‘The Chaum’ which is a filler product, the most to loosen or dented parts caused by facial tissue loss and etc.
popularly used in plastic surgery and cosmetic field along with botu-
linum toxin. Also, we accelerate our growth by introducing facial lifting R&D Pilpeline
product (Blue Rose), cosmeceutical (Wellage), and etc. to create synergy Pipeline Description DS PC PⅠ PⅡ PⅢ NDA
effect with existing products. We, Hugel Inc., try to grow as an interna- siRNA products to prevent
tional specialty pharmaceutical company that continuously research and BMT101 and inhibit intractable ○
develop pharmaceutical products in various markets including indication hypertrophic scar
expansion of botulinum toxin, scar treatment development and etc.
CEO
Dynamic equinus foot
Kyeong Yeop Moon deformity in children with ○
Botulax cerebral palsy
Location
61-20, Sinbuk-ro, Sinbuk-eup, (Botulinum Post stroke upper limb
○
Chuncheon-si, Gangwon-do, neurotoxin spasticity
24206, Korea Type A) Hyperhidrosis ○
Homepage Painless liquid product
www.hugel.co.kr
○
development

36 37